Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
Open Access
- 1 February 1987
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 138 (3), 963-974
- https://doi.org/10.4049/jimmunol.138.3.963
Abstract
The anti-tumor activity of recombinant human tumor necrosis factor (rHTNF) was examined against four newly induced murine sarcomas (MCA-101, -102, -10This publication has 40 references indexed in Scilit:
- Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factorInfection and Immunity, 1981
- Preliminary characterization of the tumor cell cytotoxin in tumor necrosis serum.The Journal of Immunology, 1981
- PRODUCTION OF AN ANTI-TUMOR CYTO-TOXIN BY HUMAN-MONOCYTES1981
- Rabbit tumor necrosis factor: mechanism of actionInfection and Immunity, 1981
- Macrophages as a source of tumoricidal activity (tumor-necrotizing factor)Infection and Immunity, 1980
- Purification and physico-chemical characterization of rabbit tumor necrosis factor.The Journal of Immunology, 1980
- Pulmonary Metastases From Autochthonous 3-Methylcholanthrene-Induced Murine TumorsJNCI Journal of the National Cancer Institute, 1979
- Effects of Murine Tumor Necrosis Factor on Heterotransplanted Human TumorsPathobiology, 1979
- The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity.The Journal of Experimental Medicine, 1978
- Corynebacterium parvum as the Priming Agent in the Production of Tumor Necrosis Factor in the Mouse2JNCI Journal of the National Cancer Institute, 1977